Reports for PFIZER CANADA ULC
Company Name
PFIZER CANADA ULC
Totals |
||
Shortage reports |
755 |
|
Actual shortage: | 85 (11%) | |
Anticipated shortage: | 10 (1%) | |
Avoided shortage: | 48 (6%) | |
Resolved: | 612 (81%) | |
Discontinuation Reports |
87 |
|
To be discontinued: | 1 (1%) | |
Discontinued: | 85 (98%) | |
Reversed: | 1 (1%) | |
Late reports |
20 (2%) |
|
Overdue reports |
9 (9%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
NIPRIDE | 25MG | SOLUTION | Resolved | 2023-08-02 | 2023-09-13 | 200680 |
METHOTREXATE INJECTION USP | 25MG | SOLUTION | Resolved | 2024-01-10 | 2024-01-23 | 215532 |
METHOTREXATE INJECTION USP | 25MG | SOLUTION | Anticipated shortage | 2024-05-15 | 2024-05-15 | 228024 |
DEFEROXAMINE MESYLATE FOR INJECTION | 2G | POWDER FOR SOLUTION | Resolved | 2017-04-13 | 2017-07-11 | 6772 |
CEFTRIAXONE SODIUM FOR INJECTION BP | 2G | POWDER FOR SOLUTION | Resolved | 2017-11-15 | 2018-07-26 | 29321 |
DEFEROXAMINE MESYLATE FOR INJECTION | 2G | POWDER FOR SOLUTION | Resolved | 2020-04-01 | 2020-05-26 | 110345 |
CEFTRIAXONE SODIUM FOR INJECTION BP | 2G | POWDER FOR SOLUTION | Resolved | 2020-09-21 | 2021-04-06 | 124615 |
DEFEROXAMINE MESYLATE FOR INJECTION | 2G | POWDER FOR SOLUTION | Resolved | 2022-07-20 | 2022-08-18 | 165089 |
DEFEROXAMINE MESYLATE FOR INJECTION | 2G | POWDER FOR SOLUTION | Avoided shortage | 2022-10-26 | 2022-12-05 | 172596 |
DEFEROXAMINE MESYLATE FOR INJECTION | 2G | POWDER FOR SOLUTION | Resolved | 2023-11-30 | 2024-04-18 | 212030 |
DEMULEN 30 (21 DAY PACK) | 2MG 30MCG | TABLET | Resolved | 2017-09-21 | 2018-04-12 | 22959 |
DEMULEN 30 (21 DAY PACK) | 2MG 30MCG | TABLET | Resolved | 2019-02-21 | 2019-07-04 | 76594 |
EPIRUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2017-03-13 | 2018-07-26 | 1081 |
MITOXANTRONE INJECTION USP | 2mg | Solution | Resolved | 2017-03-13 | 2017-09-25 | 1148 |
CISATRACURIUM BESYLATE INJECTION | 2MG | SOLUTION | Resolved | 2017-03-13 | 2019-03-28 | 1428 |
TOMUDEX | 2MG | SOLUTION | Resolved | 2017-03-14 | 2017-06-01 | 2496 |
ATIVAN | 2MG | TABLET | Avoided shortage | 2017-11-06 | 2017-12-06 | 28375 |
SYNAREL | 2MG | METERED-DOSE AEROSOL | Resolved | 2018-01-16 | 2018-01-24 | 36018 |
DOXORUBICIN | 2MG | SOLUTION | Resolved | 2018-02-21 | 2019-05-02 | 40515 |
TOMUDEX | 2MG | POWDER FOR SOLUTION | Resolved | 2018-09-06 | 2018-10-13 | 60044 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MIDAZOLAM INJECTION | 5MG | SOLUTION | Reversed | 2020-10-07 | 2020-10-19 | 125902 |
ARICEPT RDT | 5MG | TABLET (ORALLY DISINTEGRATING) | To be discontinued | 2021-04-14 | 2021-04-14 | 137465 |
ROPIVACAINE HYDROCHLORIDE INJECTION USP | 5MG | SOLUTION | Discontinued | 2022-09-30 | 2022-10-02 | 170502 |
TRACE ELEMENTS INJECTION USP | 6.0MCG 0.42MG 1.67MG 0.37MG | SOLUTION | Discontinued | 2018-10-09 | 2019-03-13 | 63474 |
ZYVOXAM 600 MG | 600MG | TABLET | Discontinued | 2020-01-17 | 2022-01-17 | 103480 |
VIRACEPT | 625MG | TABLET TABLET | Discontinued | 2021-09-03 | 2021-10-29 | 145167 |
PACLITAXEL FOR INJECTION | 6MG | SOLUTION | Discontinued | 2017-07-11 | 2018-02-01 | 15446 |